Clinical Trials Logo

Clinical Trial Summary

To evaluate safety and efficacy of the combination cisplatin plus irinotecan in the treatment of biliary tract cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01859728
Study type Interventional
Source Barretos Cancer Hospital
Contact Lucas V dos Santos, MD
Phone +5517-81544670
Email lucasvsantos@yahoo.com
Status Recruiting
Phase Phase 2
Start date January 2013
Completion date December 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06101277 - Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) N/A
Completed NCT02626195 - Preoperative Nutritional Support in Malnutritional Cancer Patients N/A
Completed NCT01401894 - Perception Prognosis, Goals of Treatment, and Communication N/A
Completed NCT00551096 - Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors Phase 1
Recruiting NCT04517448 - Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
Recruiting NCT04644068 - Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies Phase 1/Phase 2
Recruiting NCT05849480 - A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC) Phase 1/Phase 2
Completed NCT02703714 - Pembrolizumab and GM-CSF in Biliary Cancer Phase 2
Completed NCT01853618 - Tremelimumab With Chemoembolization or Ablation for Liver Cancer Phase 1/Phase 2
Recruiting NCT05462314 - Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Recruiting NCT05517811 - Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Active, not recruiting NCT01661114 - A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers Phase 2
Withdrawn NCT04480190 - Neoadjuvant Therapy in Biliary Adenocarcinoma Phase 1
Completed NCT00626158 - Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers Phase 1
Terminated NCT04566133 - Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). Phase 2
Completed NCT02930252 - Covered Versus Uncovered SEMS for Palliation of Malignant Biliary Strictures. N/A
Recruiting NCT02628067 - Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Phase 2
Terminated NCT00868998 - GTX Regimen for Biliary Cancers Phase 2
Terminated NCT02908451 - A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer Phase 1
Terminated NCT01773785 - Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Phase 2